KRAS and non-small cell lung carcinoma: Our studies suggest that inhibition of PKCδ in K-ras dependent NSCLC may decrease the expression of integrin αVβ3, a known regulator of cell survival in vitro, and a factor associated with metastasis in vivo and in patients.